Genetic changes through allelic loss and
nucleic acid or
protein modifications are the main contributors to loss of function of
tumor suppressor proteins. In particular, epigenetic silencing of genes by promoter hypermethylation is associated with increased
tumor severity and poor survival. The RASSF (Ras association domain family) family of
proteins consists of 10 members, many of which are
tumor suppressor proteins that undergo loss of expression through promoter methylation in numerous types of
cancers such as
leukemia,
melanoma, breast, prostate, neck, lung, brain, colorectal and
kidney cancers. In addition to their
tumor suppressor function, RASSF
proteins act as scaffolding agents in microtubule stability, regulate mitotic cell division, modulate apoptosis, control cell migration and cell adhesion, and modulate NFκB activity and the duration of
inflammation. The ubiquitous functions of these
proteins highlight their importance in numerous physiological pathways. In this review, we will focus on the
biological roles of the RASSF family members and their regulation.